Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)N. Costedoat‐Chalumeau, Alain Dupuy, Laurent Pérard et al.|Annals of the Rheumatic Diseases|2012Cited by 207
Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literatureSébastien Sanges, David Launay, Sébastien Rivière et al.|Autoimmunity Reviews|2017Cited by 63
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysisTiphaine Lenfant, Olivier Fain, Gaëlle Leroux et al.|Lara D. Veeken|2020Cited by 51
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory DomainsMedha Barbhaiya, Thomas Dörner, Stéphane Zuily et al.|Current Rheumatology Reports|2025Cited by 0